James Flicker, most recently Citigroup's global head of paper and forest products banking, has left the bulge bracket for Greenhill & Co., the third banker to do so this year.
CCMP Capital will see Greg Brenneman, currently the chief executive of sandwich chain Quiznos, join its ranks as chairman and investment committee member at the end of next month. Brenneman is known for steering companies through turnaround processes.
Fridson Investment Advisors said on Monday it appointed Karen Sterling and Paul Horng to its research team.
The latest in ratings downgrades and outlooks from Moody's and S&P.
Baird Venture Partners, the venture capital investment arm of Robert W. Baird & Co., said Monday that it has closed on more than $170 million for its third venture fund.
Apax Partners is planning to chart its next big move with the sale of a 10% stake to Australian and Singaporean sovereign wealth funds, valuing it at $2.9 billion, or £1.5 billion, according to news reports last Tuesday.
When news surfaced this past week that Indian business mogul Anil Ambani's Reliance Capital was planning to raise $1 billion for a new India-focused private equity fund and Tata Capital had appointed banking veteran Shailendra Bhandari to run its private equity operations, the developments reinforced how much interest India's corporations have in investment prospects in their own backyard.
Few topics these days generate as robust a debate as the state of our healthcare system. Whether it's the spiraling cost of care, new medical technologies or disease prevention, it seems everyone has their thoughts on where the industry is heading. Indeed, one of the best indictors of the importance of healthcare in this country can be seen and heard on a daily basis, as the presumptive US Presidential nominees spar over various issues impacting the industry. So, what better time to gather a host of industry experts and discuss one of the most important issues facing our country?
The market for initial public offerings isn't particularly robust at the moment, but that doesn't mean that attorneys who handle IPOs aren't optimistic about the prospects for the coming year.
The credit crunch and slowing domestic business growth have stalled buyout dealmaking in the US, but some domestic private equity firms are putting their money to work another way: investing in far-off lands. Businesses in Africa, China and India, as well as the Middle East, Central and Eastern European regions are drawing capital, as are funds that invest in emerging markets. Whether those emerging market investments will prove to be the US private equity industry's next eureka moment or another elusive treasure hunt remains to be seen.